Redmile Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Redmile Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,838,376	Closed	-$47.7M	–	65
2016 Q4	$47.7M	Buy	3,838,376 +1,699,905	+79%	+$20.5M	4.12%	6
2016 Q3	$29.3M	Buy	+2,138,471	New	+$21.5M	2.33%	16
2013 Q4	–	Sell	-1,264,009	Closed	-$23.3M	–	68
2013 Q3	$23.3M	Sell	1,264,009 -13,100	-1%	-$254K	3.5%	10
2013 Q2	$22.3M	Buy	+1,277,109	New	+$22.6M	3.94%	8

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Redmile Group's ARIA Position: Q1 2017 in Review

Redmile Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 3,838,376 shares — an estimated $47.7M sold.

Redmile Group first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $47.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Redmile Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Redmile Group sold 3,838,376 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $47.7M.
Redmile Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
Redmile Group's Ariad Pharmaceuticals Inc position peaked at $47.7M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Redmile Group's 13F filing for Q1 2017, filed 15 May 2017.